The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
about
Inferring protein modulation from gene expression data using conditional mutual information.Myc suppression of Nfkb2 accelerates lymphomagenesis.Burkitt lymphoma: pathogenesis and immune evasion.Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic response.Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma.The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock.Oncogenic mechanisms in Burkitt lymphomaNF-κB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism.Prognostic value of expression of nuclear factor kappa-B/p65 in non-GCB DLBCL patients.c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas.Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation.MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.Mutual interaction between BCL6 and miRNAs contributing to the pathogenesis of various cancers.TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms.HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling.BET bromodomain inhibitors synergize with ATR inhibitors to induce DNA damage, apoptosis, senescence-associated secretory pathway and ER stress in Myc-induced lymphoma cells.Cyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-κB and Bcl-2 families.Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphoma.Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in Cancer.
P2860
Q30860211-F636AB86-A700-4859-A361-BD3F29417F45Q33624136-8F16AB26-D70A-41E4-8F3D-1E3B877EF2C9Q34189497-56A25443-5CE7-4122-B9B0-97B0EC41BE80Q34631363-3BE5925D-336B-433D-8D27-40C31BFABBA3Q34646755-85AAC0E1-8FC8-410A-9B0D-0F2E3A1E1D19Q36204234-DA935157-CF22-491A-BE6F-D03BC8C8C33AQ36204839-12D8BFF9-0B40-42D9-B4A2-6C9FBEF45259Q36846723-6CE47437-37EE-4D77-BB3A-1F8A1368669FQ37522401-4D6B4A5A-3D89-42AF-900A-2F314BF10909Q37579738-C6AC16C6-C4CB-45B2-9364-64D7E2B8AB2CQ37706051-CF539B37-87F0-47CE-83DA-86FA6203EC7FQ37833424-FC1FC6BF-1134-4F2F-89B5-79C5FC4EEA1FQ38147318-AFA69F7C-D9A0-4578-A669-D00EACC5BBF1Q38174306-6B60B813-AC29-42BC-8460-5854AC12D0B7Q38233772-820169DD-F8D8-443E-BF86-33A213C0D3C1Q38537155-8DEEF73B-61AD-42B5-9955-E195D3BFCBB3Q38576172-D9925808-A16B-4952-AFAE-8BDBDA624027Q38722432-D7F3CF5B-FC86-465F-A3D7-91279EDE19A1Q38799987-DCA6AE77-85DB-4665-A8E5-4B8E8C001C12Q39931378-C6873267-076A-4CAF-92C6-6B338DB01848Q42261435-4C88D363-2AD8-4D89-ACE7-43908F006D36Q42701290-38D8DE5F-A049-4E52-903F-D6C5B2784FE0Q45364712-E56EAAFD-CFCA-4D7D-9965-EAB95B50AA08Q52722878-10727E4F-D31E-4540-B3F8-765F893F0A86
P2860
The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
@en
The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
@nl
type
label
The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
@en
The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
@nl
prefLabel
The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
@en
The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
@nl
P2093
P1433
P1476
The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis
@en
P2093
Bernd Baumann
Kay Klapproth
Sandrine Sander
Thomas Wirth
P304
P356
10.1182/BLOOD-2008-09-181008
P407
P577
2009-07-23T00:00:00Z